Mirvetuximab Soravtansine Offers New Hope For Women With Platinum-Resistant Ovarian Cancer, Say Experts liveindia.tv/health/mirvetux… via @LiveIndia #OvarianCancer #MirvetuximabSoravtansine #Elahere #CancerTreatment #PrecisionMedicine #TargetedTherapy #Oncology #CancerResearch #Women'sHealth #MIRASOLTrial #Healthcare #MedicalBreakthrough #CancerCare #FRAlpha #AdvancedCancer

This study reveals that #Necroptosis induces inflammatory #Interferon signatures in patient-derived metastatic #BreastCancer organoids, highlighting a potential link between cell death pathways and #ImmuneModulation in #AdvancedCancer. @PampaLsfm4life #STTT #OpenAccess: doi.org/10.1038/s41392-026-0…

Advance Publication Overview of Cancer Rehabilitation Provided in Palliative Care Units in Japan: A Nationwide Survey doi.org/10.1298/ptr.25-E1037… #CancerRehabilitation #PalliativeCareUnit #AdvancedCancer #Intervention

#AudioVisualAbstract : Understanding Curability and Life Expectancy in #SurgicalPatients with #AdvancedCancer : A Mixed Methods Analysis of Factors that Affect Views on #CancerPrognosis @DrByrneLee ow.ly/3ZTi50Z0hU8 @AnishJayJain @SyedAAhmad5

কখন দরকার প্যালিয়েটিভ কেয়ার? When is Palliative Care needed? #PalliativeCare #CancerCare #HospiceCare #AdvancedCancer #CancerAwareness #QualityOfLife #PatientSupport #thewallarogya

#PatientVoice #CaregiverVoice #CancerAdvocacy #HealthCareInCanada #MetastaticCancer #AdvancedCancer #CancerTreatment #HTA #PatientExperience #CancerSupport #Cancer #LungCancer #SCLC #HealthPolicy

#PatientVoice #CaregiverVoice #CancerAdvocacy #HealthCareInCanada #MetastaticCancer #AdvancedCancer #CancerTreatment #HTA #PatientExperience #CancerSupport #Cancer #LungCancer #SCLC #HealthPolicy

.@YaleCancer #GrandRounds, Dr. Prasanna Ananth asks, “What defines high-quality end-of-life care for children with #cancer?” and provides insight into both what and how we measure what is most important to families with children facing #advancedcancer. #childhoodcancer. Watch her full talk youtube.com/watch?v=4zPhlgKF… @SmilowCancer @YalePediatrics

𝗦𝗲𝗲𝗸𝗶𝗻𝗴 𝗣𝗮𝘁𝗶𝗲𝗻𝘁𝘀 𝘄𝗶𝘁𝗵 #𝗔𝗱𝘃𝗮𝗻𝗰𝗲𝗱𝗖𝗮𝗻𝗰𝗲𝗿 𝗳𝗼𝗿 𝗡𝗲𝘄 #𝗖𝗹𝗶𝗻𝗶𝗰𝗮𝗹𝗦𝘁𝘂𝗱𝘆 | #CuriousDrGeorge & Prajit Pillai, PhD, MBA—Cancer Commons Director, Clinical Sciences: bit.ly/CCCDGPillai #CancerResearch #PrecisionOncology #ClinicalTrial

🚨 Latest #Phase 3 Trial Update! 🔷 Deutenzalutamide, a novel androgen receptor inhibitor, demonstrated clinical activity in patients with metastatic castration-resistant prostate cancer previously treated with Docetaxel and Abiraterone in the Phase 3 HC-1119-04 trial. 🔷 The study showed a significant improvement in radiographic progression-free survival (HR 0.58), supporting its potential in this challenging setting. 🔷 These findings provide important insights into treatment sequencing and reinforce the continued relevance of AR pathway targeting after progression on standard therapies, helping inform clinical decision-making in advanced prostate cancer. 🔗 Read more: bit.ly/ONCOnews-14-Apr-01 #ONCOnews #OncoAlert #OncEd #Oncology #ProstateCancer #mCRPC #CancerResearch #Oncologist #MedEd #MedicalEducation #CancerCare #ClinicalTrials #Phase3Trial #DrugDevelopment #AndrogenReceptor #TargetedTherapy #PrecisionMedicine #UroOncology #AdvancedCancer #TreatmentStrategies #ClinicalPractice #EvidenceBasedMedicine #HealthcareProfessionals #MedCommunity #Doctors #MedLife #StayUpdated #Pharma #Biotech #ResearchUpdate #InnovationInMedicine

These are scientific breakthroughs from space missions -AdvancedCancer Therapies -​3D Bioprinting of Organs -​Muscle & Bone Loss Prevention -​Low-temperature combustion science -Discovering ​The Fifth State of Matter -I​mproving household product shelf-life -​Understanding bacterial mutations and antibiotics -​Water recovery and air purification systems Bro we need these missions

A majority of older patients with #advancedcancer have indicated they prioritize quality of life over extending survival. Published by @JAMAOnc and @CancerTherAdvsr. bit.ly/4diCYk4 #QOL #cancercare

Qualifying Conditions for Social Security’s Compassionate Allowance Click the bio link to listen to the full episode. bio.link/ericpines #SocialSecurityDisability #CompassionateAllowance #SSDI #DisabilitySupport #FastTrackBenefits #ALS #AdvancedCancer

A majority of older patients with #advancedcancer have indicated they prioritize #QOL over extending survival. Published by @JAMAOnc. bit.ly/47FVkb8 #CancerCare

🚨 The latest #Oncology Update! 🔷 The Phase III DELII trial assesses the efficacy and safety of ultra-low dose immunotherapy in relapsed or refractory solid tumors. 🔷 Patients were randomized to ultra-low-dose nivolumab 20 mg every 2 weeks versus standard chemotherapy, with median OS of 5.88 vs 4.70 months (HR, 0.80) as the primary endpoint. 🔗 Read more: bit.ly/ONCOnews29J-02 #ONCOnews #OncoAlert #OncEd #SolidTumors #CancerResearch #AdvancedCancer #Immunotherapy #ClinicalTrials

Our Patients, Their Experiences ⭐⭐⭐⭐⭐ . Consult Dr. Neeraj Chaudhary Best Pancreatic Surgeon in Vasant Kunj . 📞 96504 24751, 84471 27840 . #DrNeerajChaudhary #OurPatientsTheirExperiences #PatientReviews #TrustedCare #GutCare #HealthWarning #AdvancedSurgery #AdvancedCancer

📢 Big strides in survivorship research for advanced & metastatic cancers! Read here: linkedin.com/feed/update/urn… #survonc #advancedcancer #metastaticcancer

हिमाचल में स्वास्थ्य सेवाओं को नई दिशा 🚑 जाइका के सहयोग से 1731 करोड़ रुपये का हेल्थ प्रोजेक्ट मंजूर 💊 मेडिकल कॉलेजों में आधुनिक सुविधाएं और हमीरपुर में 300 करोड़ का एडवांस कैंसर सेंटर स्थापित होगा 🏥 #HimachalHealthcareReform #JICAproject #AdvancedCancer

✨#ESMO25✨ 🚨BREAKING: KEYTRUDA® (pembrolizumab) LENVIMA® (lenvatinib) in Advanced Endometrial Carcinoma – 5-Year Survival Update 📈 Durable Benefit: Five-year OS results in the pMMR subgroup are consistent with the overall population. 💡 Improved Outcomes: OS rate of 19.9% with KEYTRUDA (pembrolizumab) LENVIMA (lenvatinib) vs. 7.7% with chemotherapy. 🔗 Read more: bit.ly/ONCOnews19O-7 #ONCOnews #OncoAlert #OncEd #ESMO2025 #Oncology #EndometrialCancer #AdvancedCancer #CancerTreatment

Tonight in Berlin, the final COACH-ED Expert Meeting begins. Medical oncologists & international cachexia experts gather this evening to advance the recognition & management of cancer cachexia in advanced cancers. Join focused, expert-led discussions on: - Early diagnosis of cancer cachexia - Functional & appetite assessment in practice - Multimodal interventions to improve outcomes 19 Oct | 19:00 – 21:30 CEST This is the last opportunity to be part of COACH-ED, the Collaborative Oncology Alliance for Cachexia Education, shaping the future standard of care for cancer cachexia. Register before it’s too late: coach-edu.org/register/ #COACHEDBerlin #CancerCachexia #AdvancedCancer #MedicalOncology #OncologyEducation